Literature DB >> 18585914

Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations.

Margherita Milone1, Nicola Brunetti-Pierri, Lin-Ya Tang, Neeraj Kumar, Michelle M Mezei, Keith Josephs, Suzanne Powell, Ericka Simpson, Lee-Jun C Wong.   

Abstract

Mutations in POLG gene are responsible for a wide spectrum of clinical disorders with altered mitochondrial DNA (mtDNA) integrity, including mtDNA multiple deletions and depletion. Sensory ataxic neuropathy with ophthalmoparesis (SANDO) caused by mutations in POLG gene, fulfilling the clinical triad of sensory ataxic neuropathy, dysarthria and/or dysphagia and ophthalmoparesis, has described in a few reports. Here we described five cases of adult onset autosomal recessive sensory ataxic neuropathy with ophthalmoplegia. All patients had ataxia, neuropathy, myopathy, and progressive external ophthalmoplegia (PEO). The muscle pathology revealed ragged-red and cytochrome c oxidase (COX) negative fibers in three patients. However, deficiencies in the activities of mitochondrial respiratory chain enzyme complexes were not detected in any of the patients' muscle samples. Multiple deletions of mtDNA were detected in blood and muscle specimens but mtDNA depletion was not found. Due to these diagnostic difficulties, POLG-related syndromes are definitively diagnosed based on the presence of deleterious mutations in the POLG gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585914     DOI: 10.1016/j.nmd.2008.05.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  15 in total

1.  Late-onset presentation of POLG1-associated mitochondrial disease.

Authors:  Bruna Meira; Rafael Roque; Miguel Pinto; André Caetano
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories.

Authors:  Lee-Jun C Wong
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Characteristic brain MRI findings in ataxia-neuropathy spectrum related to POLG mutation.

Authors:  Adriana I Henao; Sonia Pira; Diego A Herrera; Sergio A Vargas; Jorge Montoya; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2016-01-11

4.  Rare variant of unknown significance in POLG1 and diagnostic dilemma.

Authors:  Pankaj Prasun
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

5.  Uncovering bilateral vestibulopathy in patients with SANDO syndrome caused by mutations in POLG gene: a case series.

Authors:  Alexandra Belyakova-Bodina; Mikhail Ratanov; Erich Schneider; Yury Seliverstov; Evgenii Nuzhnyi; Sergey Klyushnikov; Amayak Broutian
Journal:  J Neurol       Date:  2021-06-12       Impact factor: 4.849

Review 6.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

7.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.

Authors:  Sha Tang; Elliot L Dimberg; Margherita Milone; Lee-Jun C Wong
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

8.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Authors:  Lee-Jun C Wong; Robert K Naviaux; Nicola Brunetti-Pierri; Qing Zhang; Eric S Schmitt; Cavatina Truong; Margherita Milone; Bruce H Cohen; Beverly Wical; Jaya Ganesh; Alice A Basinger; Barbara K Burton; Kathryn Swoboda; Donald L Gilbert; Adeline Vanderver; Russell P Saneto; Bruno Maranda; Georgianne Arnold; Jose E Abdenur; Paula J Waters; William C Copeland
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

9.  Clinical and molecular features of mitochondrial DNA depletion syndromes.

Authors:  A Spinazzola; F Invernizzi; F Carrara; E Lamantea; A Donati; M Dirocco; I Giordano; M Meznaric-Petrusa; E Baruffini; I Ferrero; M Zeviani
Journal:  J Inherit Metab Dis       Date:  2008-12-27       Impact factor: 4.982

10.  Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA).

Authors:  F Mochel; F Sedel; A Vanderver; U F H Engelke; J Barritault; B Z Yang; B Kulkarni; D R Adams; F Clot; J H Ding; C R Kaneski; F W Verheijen; B W Smits; F Seguin; A Brice; M T Vanier; M Huizing; R Schiffmann; A Durr; R A Wevers
Journal:  Brain       Date:  2009-01-19       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.